BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift...
News
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
EMERYVILLE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company...
Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting
NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG),...
Anaptys Announces Participation in December Investor Conferences
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative...
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing,...
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
Actionable offering helps enable earlier, more personalized breast cancer interventionsBOSTON and SALT LAKE CITY and FULTON, Md., Nov. 25, 2025...
Surrozen to Present at Upcoming Healthcare Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology...
LENZ Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical...
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with...
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
Two late-breaking podium presentations and three posters continue to demonstrate cretostimogene as a potential backbone therapy for a broad range...
Aardvark Therapeutics to Present at Upcoming Investor Conferences in December
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on...
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
ROCKVILLE, MD, Nov. 25, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics...
Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
PHILADELPHIA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem...
Este Surgery Announces Advanced DHI Hair Transplant Technology in Turkey’s Medical Tourism Sector
Turkey Raises the Bar in Medical Tourism with Advanced DHI Hair Transplant TechnologyIstanbul, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Turkey's...
Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds
PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative...
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November...
Optimi Health to Supply MDMA to MAPS Israel’s Clinical Trial for Trauma-Related PTSD
Approved multicenter study sponsored by Sheba Medical Center to compare group and individual MDMA-assisted therapy for 168 patients experiencing trauma-related...
Edison Issues Report on Faraday Future Intelligent Electric (FFAI)
London, United Kingdom--(Newsfile Corp. - November 26, 2025) - Edison issues report on Faraday Future Intelligent Electric (NASDAQ: FFAI).Faraday Future...
Kanazawa University research: Scientists develop light-controlled method to trigger brain signals
KANAZAWA, Japan, Nov. 26, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in ACS...
Queen Square launches podcast to support Parkinson’s and Essential Tremor patients
LONDON, Nov. 26, 2025 /PRNewswire/ -- Queen Square Imaging Centre – the world-leading centre treating patients with Essential Tremor and...